Argent Biopharma (AU:RGT) has released an update.
Argent Biopharma Limited has announced the issuance of 312,500 unlisted warrants, with each warrant exercisable at US$1.20, expiring on July 3, 2027. This financial move, detailed on July 3, 2024, signals a new opportunity for investment in the biopharmaceutical company’s future growth. The warrants are part of a transaction previously communicated to the market and will not be listed on the ASX.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
